Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 294

1.
2.

Effect of regular terbutaline on the airway response to inhaled budesonide.

Wilding PJ, Clark MM, Oborne J, Bennett JA, Tattersfield AE.

Thorax. 1996 Oct;51(10):989-92.

3.

Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.

de Jong JW, van der Mark TW, Koëter GH, Postma DS.

Am J Respir Crit Care Med. 1996 Jan;153(1):70-5.

PMID:
8542165
4.
5.

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma.

Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Reinikainen K, Selroos O, et al.

N Engl J Med. 1991 Aug 8;325(6):388-92.

6.
7.

Dosage and time effects of inhaled budesonide on bronchial hyperreactivity.

Kraan J, Koëter GH, van der Mark TW, Boorsma M, Kukler J, Sluiter HJ, De Vries K.

Am Rev Respir Dis. 1988 Jan;137(1):44-8.

PMID:
3276257
8.

Relative effects of inhaled corticosteroids on immunopathology and physiology in asthma: a controlled study.

Burke CM, Sreenan S, Pathmakanthan S, Patterson J, Schmekel B, Poulter LW.

Thorax. 1996 Oct;51(10):993-9.

9.

Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge.

Wong CS, Wahedna I, Pavord ID, Tattersfield AE.

Am J Respir Crit Care Med. 1994 Nov;150(5 Pt 1):1268-73.

PMID:
7952551
10.

Propranolol inhalation challenge in relation to histamine response in children with asthma.

Gerritsen J, Koëter GH, Vander Weele LT, Knol K.

Thorax. 1988 Jun;43(6):451-5.

11.

Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma.

Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Selroos O, Sovijärvi A, et al.

N Engl J Med. 1994 Sep 15;331(11):700-5.

12.

Randomised trial of an inhaled beta2 agonist, inhaled corticosteroid and their combination in the treatment of asthma.

Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Wong CS, Taylor DR.

Thorax. 1999 Jun;54(6):482-7.

13.
14.

Eosinophils in exercise-induced asthma.

Venge P, Henriksen J, Dahl R.

J Allergy Clin Immunol. 1991 Nov;88(5):699-704.

PMID:
1955630
15.

Effects of budesonide and bambuterol on circadian variation of airway responsiveness and nocturnal symptoms of asthma.

Wempe JB, Tammeling EP, Postma DS, Auffarth B, Teengs JP, Koëter GH.

J Allergy Clin Immunol. 1992 Sep;90(3 Pt 1):349-57.

PMID:
1356117
16.
18.

Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma.

Booms P, Cheung D, Timmers MC, Zwinderman AH, Sterk PJ.

J Allergy Clin Immunol. 1997 Mar;99(3):330-7.

PMID:
9058688
19.

Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.

Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Taylor DR.

Respir Med. 2000 Aug;94(8):767-71.

20.

Effect of inhaled corticosteroids on peripheral blood eosinophil counts and density profiles in asthma.

Evans PM, O'Connor BJ, Fuller RW, Barnes PJ, Chung KF.

J Allergy Clin Immunol. 1993 Feb;91(2):643-50.

PMID:
8436777

Supplemental Content

Support Center